KM Research Hub
← 返回结果库查看论文详情PubMed ↗
READ-ONLY DIGITIZATION RESULT

Adjuvant rituximab and elevated intratumoural CD8 expression are associated with sustained disease control after radiotherapy in a randomised trial of systemic therapy in early-stage follicular lymphoma.

EBioMedicine · 2024-Dec · PMID 39631145

Panel C质量警告待 EXE 对齐验证

overall survival

Fig. 1 Outc omes of 150 patients with ESFL registered to the TROG99.03 trial with extended follow-up. A) Clinical trial schema outlining randomization and treatment received (TR) to IFRT vs. combined modality treatment (CMT) (i.e. IFRT+(R)CVP) arms. B) Progression-free survival of IFRT vs. IFRT+(R)CVP arms. C) Overall survival of IFRT+(R)CVP vs. IFRT arms. D) Hazard curves demonstrating cumulative incidence of death and histologic transformation in IFRT+(R)CVP and IFRT treatment arms.

算法:legacy-0.5.0引擎:enhanced-linux
质量评分0.68
质量通过否
预期曲线2
实际曲线1
X 范围0 – 18
Y 范围0 – 100

曲线数据

网页最多预览 200 行,完整数据请下载 CSV 或 JSON。

匹配 18 行
Curve序号X (norm)Y (norm)X (real)Y (real)X (pixel)Y (pixel)
110.00000.57530.000057.27275893
120.57680.575310.242457.272722793
130.58020.575310.303057.272722893
140.58360.575310.363657.272722993
150.58700.575310.424257.272723093
160.59040.570810.484856.818223194
170.59390.561610.545555.909123296
180.59730.561610.606155.909123396
190.60070.561610.666755.909123496
1100.60410.561610.727355.909123596
1110.60750.561610.787955.909123696
1120.61090.561610.848555.909123796
1130.61430.561610.909155.909123896
1140.61770.557110.969755.454523997
1150.62120.557111.030355.454524097
1160.62460.557111.090955.454524197
1170.62800.561611.151555.909124296
1180.63140.566211.212156.363624395
历史版本(1)

重跑只新增版本,不覆盖旧结果;正式可用状态仅授予通过 EXE 基准或人工复核的版本。

版本状态验证曲线时间
legacy-0.5.0quality_warning待验证12026-07-23T18:33:35+00:00